![Future of telehealth uncertain as CMS, private insurers reexamine payment policies put in place in March](https://cdn.cancerletter.com/media/2020/07/23154928/46-29_cover_4x3.jpg)
![Future of telehealth uncertain as CMS, private insurers reexamine payment policies put in place in March](https://cdn.cancerletter.com/media/2020/07/23154928/46-29_cover_4x3.jpg)
Cover Story
By Matthew Bin Han Ong
Summer of 2020 was supposed to be a brief period of respite between Wave 1 and Wave 2 of COVID-19, but out of sheer stubbornness, for reasons political, or both, SARS-CoV-2 didn't get the message.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
Drugs & Targets
Trending Stories
- “All in Her Head” catalogs the history of medicine’s atrocities against women
- What are you reading in 2024?
- FDA’s Brian Booth: “We need to reconsider our approach to dose selection”
- Wafik El-Deiry carted a bunch of books around the Mediterranean
Here are his reviews - How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Before the Olympics were smoke-free, tobacco brand deals ran rampant